Description
S100A8 and S100A9 (also known as MRP8 and MRP14, respectively) are Ca2+ binding proteins belonging to the S100 family. They often form heterodimers, and are endogenous danger-associated molecular patterns (DAMPs) that bind to innate immune receptors including toll-like receptor 4 (TLR4) and the receptor for advanced glycation endproducts (RAGE).
In neutrophils, S100A8 and S100A9 proteins comprise approximately 45% of the total cytoplasmic protein. During inflammation, S100A8/A9 is actively released and modulates the inflammatory response by stimulating leukocyte recruitment and inducing cytokine secretion. S100A8/A9 serves as a candidate biomarker for diagnosis and follow-up as well as a predictive indicator of therapeutic responses to inflammation-associated diseases.
This project will look at the various forms of S100A8/A9 and dissect the roles of these in inflammation and disease.
Project related methods include:
DNA cloning and protein expression, bioinformatics, western blotting, ELISA and immunohistochemistry, fluorescence and confocal microscopy, proteomics (LC-MS/MS),
Essential criteria:
Minimum entry requirements can be found here: https://www.monash.edu/admissions/entry-requirements/minimum
Keywords
inflammation, biochemistry, protein, structure, molecular biology, immunology, human pathology, diabetes, disease, medicine, structural biology, drug discovery
School
School of Translational Medicine » Diabetes
Available options
PhD/Doctorate
Masters by research
Masters by coursework
Honours
Time commitment
Full-time
Part-time
Top-up scholarship funding available
No
Physical location
Alfred Centre
Co-supervisors
Prof
Merlin Thomas